Screening for Memory Studies
1 other identifier
observational
1
1 country
1
Brief Summary
We hope to recruit participants into various clinical trials and research projects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2007
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2007
CompletedFirst Submitted
Initial submission to the registry
May 11, 2010
CompletedFirst Posted
Study publicly available on registry
May 13, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedAugust 26, 2026
August 1, 2026
16.5 years
May 11, 2010
August 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Memory Impairment
The primary outcome measure on a 50 item Continuous Recognition Task with 25 repeated items, first display of an item is 3 seconds, new image immediately after a response (MemTrax, see: reference), is number of HITs (a memory measure). Less than 20 suggests memory impairment and will trigger referral to a memory study.
90 seconds to 150 seconds (normal less than 100 seconds)
Secondary Outcomes (1)
Processing speed measurement with MemTrax
90 - 150 seconds (normal - 95 seconds)
Study Arms (1)
Older Adults
Persons over age 60 Participants will complete the Memtrax memory screening test
Interventions
Memory Screening test
Eligibility Criteria
healthy older adults with memory concerns
You may qualify if:
- Age 21 or over.
You may not qualify if:
- Major psychiatric problems.
- Major medical problems.
- Aversion to test-taking.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
VA Palo Alto Health Care System
Palo Alto, California, 94304, United States
Related Publications (2)
Ashford JW, Borson S. Primary care screening for dementia and mild cognitive impairment. JAMA. 2008 Mar 12;299(10):1132-3; author reply 1133-4. doi: 10.1001/jama.299.10.1132-b. No abstract available.
PMID: 18334685BACKGROUNDClifford JO Jr, Anand S, Tarpin-Bernard F, Bergeron MF, Ashford CB, Bayley PJ, Ashford JW. Episodic memory assessment: effects of sex and age on performance and response time during a continuous recognition task. Front Hum Neurosci. 2024 Apr 4;18:1304221. doi: 10.3389/fnhum.2024.1304221. eCollection 2024.
PMID: 38638807RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
J. Wesson Ashford Jr., MD, PhD
Stanford University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- FED
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
May 11, 2010
First Posted
May 13, 2010
Study Start
June 1, 2007
Primary Completion
December 1, 2023
Study Completion
December 1, 2023
Last Updated
August 26, 2026
Record last verified: 2026-08